The Europe ablation technologies market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 5.2% during 2023–2031. The growth of the market is attributed to increasing incidences of diseases such as cancer and cardiac ailments.
Ablation refers to negligibly invasive techniques that necessitate the surgical excision of body tissues. Ablation procedures are gaining robust popularity across the globe since they are used in minimally invasive ablation procedures.
Minimally invasive medical procedures outweigh invasive procedures because the former includes shorter recovery time, relatively lower post-procedural risks, and hospital stays. Upsurge in the demand for minimally invasive procedures on account of the aforementioned attributes will drive the growth of the Ablation Technology market.
The Covid-19 pandemic had a positive impact on the Europe ablation technologies market. The market observed rise in demand for ablation technologies owing to high patient turnaround volume and prevailing medical conditions.
Market Trends, Drivers, Restraints, and Opportunities
Lower risk of infection, lower risk of damage to tissues, quick recovery, and cost-effectiveness of ablation are some of the key factors expected to drive the market during the forecast period.
Growing base of the geriatric population across the world coupled with rising incidence rates of target conditions such as cancer and urological diseases are estimated to propel the market in coming years.
Rising unmet medical needs are likely to spur the market of ablation procedures.
Rising healthcare expenditure is anticipated to fuel the future growth of the market.
Stringent regulatory framework leading to an increase in the gestation period for product launches is projected to impede the market growth.
R&D investment and technological advancement in ablation technologies market are expected to offer lucrative opportunities for the market players.
Scope of Ablation Technologies Market Report
The report on the Europe ablation technologies market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Ablation Technologies Market - Europe Industry Analysis, Growth, Share, Size, Trends, and Forecast
Technology (Electrical, Ultrasound, Radiation, and Radiofrequency), Application (General Surgery, Cardiovascular Disease Treatment, Cancer Treatment, Ophthalmological Treatment, Gynecological Treatment, Urological Treatment, Orthopedics, Cosmetic Surgery, and Others)
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report
Boston Scientific Corporation, Conmed Corporation, Smith & Nephew PLC, Medtronic PLC, and Olympus Corporation
Ablation Technologies Market Segment insights
The radiation segment is projected to constitute a large market share
Based on technology, the Europe ablation technologies market is segregated into electrical, ultrasound, radiation, and radiofrequency. The radiation segment is expected to account for a key share of the market during the forecast period owing to its applicability in the treatment of cancer.
The cancer treatment segment is expected to register a substantial CAGR
Based on application, the Europe ablation technologies market is divided into general surgery, cardiovascular disease treatment, cancer treatment, ophthalmological treatment, gynecological treatment, urological treatment, orthopedics, cosmetic surgery, and others.
The cancer treatment segment accounts for a key share of the market and is estimated to propel even further over the forecast period owing to rising number to cancer patients and increasing awareness about ablation technology for the treatment of cancer. Cancer ablation is a minimally invasive surgical method to treat solid cancers. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor.
The Europe ablation technologies market has been segmented on the basis of:-
- General Surgery
- Cardiovascular Disease Treatment
- Cancer Treatment
- Ophthalmological Treatment
- Gynecological Treatment
- Urological Treatment
- Cosmetic Surgery
Key players competing in the Europe ablation technologies market include Boston Scientific Corporation, Conmed Corporation, Smith & Nephew PLC, Medtronic PLC, and Olympus Corporation
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.